NASDAQ:BIAFW bioAffinity Technologies Earnings Date & Estimates $0.15 +0.00 (+0.27%) As of 01:04 PM Eastern This is a fair market value price provided by Massive. Learn more. bioAffinity Technologies is estimated to report earnings on Wednesday, November 18, 2026, after market closes. Research:Profile Upcoming Earnings Announcement Announcement DateNovember 18, 2026TimeAfter Market Closes Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from bioAffinity TechnologiesbioAffinity Technologies is expected to post earnings of -$31.50 per share on revenue of $1.91 million.Consensus EstimatesConsensus EPS-$31.50Expected Revenue$1.91 millionPrepare for the Earnings CallCompany Profile bioAffinity Technologies Earnings FAQ When does bioAffinity Technologies report earnings? bioAffinity Technologies (NASDAQ:BIAFW) is estimated to report earnings on Wednesday, November 18, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What is the consensus EPS estimate for bioAffinity Technologies? Analysts expect bioAffinity Technologies to post earnings of -$31.50 per share for the quarter. How much revenue is bioAffinity Technologies expected to report? The consensus revenue estimate for bioAffinity Technologies is $1.91 million for the quarter. bioAffinity Technologies Earnings HeadlinesbioAffinity Technologies (NASDAQ:BIAFW) Shares Break Below 200 Day Moving Average - Here's What HappenedNovember 10 at 4:23 AM | americanbankingnews.combioAffinity Technologies reports 200% revenue growth, expands lung diagnostics strategyOctober 27, 2026 | finance.yahoo.comA free stock pick, from me to youElon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.November 10 at 1:00 AM | Behind the Markets (Ad)bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026October 15, 2026 | finance.yahoo.comWallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The ...October 8, 2026 | markets.ft.combioAffinity Technologies, Inc. Announces Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq ...October 8, 2026 | finance.yahoo.comSee More bioAffinity Technologies Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like bioAffinity Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on bioAffinity Technologies and other key companies, straight to your email. Email Address About bioAffinity TechnologiesbioAffinity Technologies (NASDAQ:BIAFW) is a biotechnology company focused on developing diagnostic tests for the early detection of lung cancer and other diseases. Its work combines cellular analysis and other diagnostic technologies to support earlier identification of disease. The company’s lead product, CyPath Lung, is a diagnostic test that analyzes sputum samples using flow cytometry to help assess the likelihood of lung cancer. The test is processed through Precision Pathology Laboratory Services, a subsidiary of bioAffinity Technologies. Based in San Antonio, Texas, bioAffinity Technologies has focused its commercial and development activities on lung cancer diagnostics. Maria Zannes has served as the company’s president and chief executive officer.View bioAffinity Technologies ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles DraftKings Just Lost 20%—And Its Biggest Gamble Is Still AheadBarrick's Earnings Beat Could Be Overshadowed by an Even Bigger OpportunityAxon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?Wall Street May Be Making a Big Mistake With monday.com StockCloudflare's 20% Sell-Off May Have Created an Opening for InvestorsMarketBeat Week in Review – 11/2 - 11/6 Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
